IOVS British Journal of Pharmacology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:1763-1770.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0885

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kikuchi, M.
Right arrow Articles by Joyce, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kikuchi, M.
Right arrow Articles by Joyce, N. C.

p27kip1 Antisense-Induced Proliferative Activity of Rat Corneal Endothelial Cells

Michiharu Kikuchi,1,2 Deshea L. Harris,1 Yoshitaka Obara,2 Tadashi Senoo,2 and Nancy C. Joyce1

1From the Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and the 2Department of Ophthalmology, Dokkyo University School of Medicine, Tochigi, Japan.

PURPOSE. To determine whether antisense downregulation of p27kip1 will overcome G1-phase arrest and promote cell cycle progression in rat corneal endothelial cells (CECs).

METHODS. Confluent cultures of rat CECs were incubated for 24 hours in the presence of p27kip1 antisense (AS) oligonucleotides (oligoS) using nonliposomal lipid transfection. Control cultures were incubated under one of the following conditions: no oligos or lipid-containing buffer, lipid-containing buffer alone, or lipid-containing buffer plus missense (MS) p27kip1 oligo. Viability was tested by a cell-viability assay after 0, 24, 48, and 72 hours. After postincubation for 0, 24, 48, or 72 hours, cultures were fixed and immunostained for p27kip1, to test for downregulation, or for Ki67 or BrdU, to detect actively cycling cells. Western blot and immunocytochemistry (ICC) studies were conducted to determine the effect of p27kip1 antisense treatment on the relative protein level and subcellular localization of several cell cycle proteins, including cyclin-D1, -E, -A, and -B1; CDK2 and -4; p21cip1; and p15INK4b. Proliferation was determined by direct counting of propidium iodide (PI) or 4',6'-diamino-2-phenylindole (DAPI)-stained cells.

RESULTS. Viability was not significantly affected by lipid-based oligo transfection for up to 48 hours, after which a decline was noted. The protein level of p27kip1 was reduced after AS transfection in a time-dependent manner. Nuclear staining for p27kip1 was greatly reduced in CECs incubated with AS oligo. No change in p27kip1 levels was observed in controls at any time point tested. p27kip1 AS oligo transfection increased cyclin-D1, -E, -A, and -B1 protein levels, and all cyclins were localized to the nucleus. No changes in protein level were observed for CDK2, CDK4, p21cip1, or p15INK4B. A time-dependent increase in the relative number of Ki67- and BrdU-positive cells was noted in CECs incubated with AS oligo. In contrast, no to few Ki67- or BrdU-positive cells were observed in CECs incubated with MS oligo or the buffer-treated control cells. The percentage increase in the number of cells transfected with AS oligo increased with time, compared with that of cells transfected with MS oligo.

CONCLUSIONS. Treatment with p27kip1 antisense oligonucleotides followed by postincubation in 10% FBS lowers endogenous p27kip1 protein levels and promotes proliferation in confluent cultures of rat CECs.





This article has been cited by other articles:


Home page
IOVSHome page
Y. Nakano, M. Oyamada, P. Dai, T. Nakagami, S. Kinoshita, and T. Takamatsu
Connexin43 Knockdown Accelerates Wound Healing but Inhibits Mesenchymal Transition after Corneal Endothelial Injury In Vivo
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 93 - 104.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. G. Lee and E. P. Kay
Involvement of Two Distinct Ubiquitin E3 Ligase Systems for p27 Degradation in Corneal Endothelial Cells
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 189 - 196.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. H. Suh, C. Zhang, R. S. Chuck, W. J. Stark, S. Naylor, K. Binley, S. Chakravarti, and A. S. Jun
Cryopreservation and Lentiviral-Mediated Genetic Modification of Human Primary Cultured Corneal Endothelial Cells
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3056 - 3061.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Kikuchi, C. Zhu, T. Senoo, Y. Obara, and N. C. Joyce
p27kip1 siRNA Induces Proliferation in Corneal Endothelial Cells from Young but Not Older Donors
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4803 - 4809.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Enomoto, T. Mimura, D. L. Harris, and N. C. Joyce
Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4330 - 4340.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology